GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (HAM:GS70) » Definitions » Interest Coverage

GSK (HAM:GS70) Interest Coverage : 1.21 (As of Sep. 2024)


View and export this data going back to 1987. Start your Free Trial

What is GSK Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. GSK's Operating Income for the three months ended in Sep. 2024 was €225 Mil. GSK's Interest Expense for the three months ended in Sep. 2024 was €-186 Mil. GSK's interest coverage for the quarter that ended in Sep. 2024 was 1.21. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for GSK's Interest Coverage or its related term are showing as below:

HAM:GS70' s Interest Coverage Range Over the Past 10 Years
Min: 3.58   Med: 7.66   Max: 10.17
Current: 9.24


HAM:GS70's Interest Coverage is ranked worse than
56.84% of 658 companies
in the Drug Manufacturers industry
Industry Median: 13.2 vs HAM:GS70: 9.24

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


GSK Interest Coverage Historical Data

The historical data trend for GSK's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

GSK Interest Coverage Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.16 5.40 6.38 8.15 10.13

GSK Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.71 7.57 8.98 9.46 1.21

Competitive Comparison of GSK's Interest Coverage

For the Drug Manufacturers - General subindustry, GSK's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Interest Coverage distribution charts can be found below:

* The bar in red indicates where GSK's Interest Coverage falls into.



GSK Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GSK's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, GSK's Interest Expense was €-842 Mil. Its Operating Income was €8,526 Mil. And its Long-Term Debt & Capital Lease Obligation was €17,649 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*8525.778/-841.551
=10.13

GSK's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the three months ended in Sep. 2024, GSK's Interest Expense was €-186 Mil. Its Operating Income was €225 Mil. And its Long-Term Debt & Capital Lease Obligation was €15,784 Mil.

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*225.25/-185.921
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


GSK  (HAM:GS70) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


GSK Interest Coverage Related Terms

Thank you for viewing the detailed overview of GSK's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines